4//SEC Filing
Young Diane C. 4
Accession 0001415889-22-008895
CIK 0000744218other
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 4:05 PM ET
Size
12.7 KB
Accession
0001415889-22-008895
Insider Transaction Report
Form 4
Young Diane C.
SVP, CHIEF MEDICAL OFFICER
Transactions
- Exercise/Conversion
Incentive Stock Option
2022-08-17−19,000→ 48,400 totalExercise: $10.38Exp: 2030-06-18→ Common Stock (19,000 underlying) - Exercise/Conversion
Common Stock
2022-08-17$10.38/sh+19,000$197,220→ 21,115 total - Exercise/Conversion
Common Stock
2022-08-17$2.71/sh+45,000$121,950→ 47,115 total - Exercise/Conversion
Incentive Stock Option
2022-08-17−45,000→ 15,000 totalExercise: $2.71Exp: 2029-07-08→ Common Stock (45,000 underlying) - Sale
Common Stock
2022-08-17$37.30/sh−19,000$708,715→ 2,115 total
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.30 to $37.35 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- [F2]25% vested on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.
- [F3]25% vested on July 8, 2020 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.
Documents
Issuer
Celldex Therapeutics, Inc.
CIK 0000744218
Entity typeother
Related Parties
1- filerCIK 0001648010
Filing Metadata
- Form type
- 4
- Filed
- Aug 18, 8:00 PM ET
- Accepted
- Aug 19, 4:05 PM ET
- Size
- 12.7 KB